Literature DB >> 22552841

["Dangerous" cutaneous polyp. Exophytic cutaneous myxofibrosarcoma].

B E Paredes1, T Mentzel, R Denfeld.   

Abstract

Malignant skin tumors are seldom polypoid lesions. Thus lesions presenting as large skin tags, as in this case, may initially not be recognized and treated as a malignancy. Often such protuberant lesions are removed by shave biopsy. Then, as in this case, the clinician is very surprised to receive the diagnosis of myxofibrosarcoma (MFS). This case shows how important it is to further investigate a common tumor, like a large skin tag, when its clinical appearance is unusual. Myxofibrosarcoma or myxoid malignant fibrous histiocytoma is one of the common, perhaps most common, sarcoma in adults. Clinical presentation as a large skin tag is extremely uncommon. The rapid growth of the polypoid sarcoma indicates the need for completely operative removal. The behavior of the MFS depends on the degree of malignancy, depending on the tumor size, depth of penetration and local control. While smaller dermal or subcutaneous localized MFS hold potentially a risk of recurrence, do larger examples with a high tumor grade and seated in the deep soft tissue posses a variable metastatic potential. Despite large variability of cell number, cellular atypia and the numbers of mitotic figures all myxofibrosarcoma have in common the multinodular structure with incomplete septa, the mucinous stroma and curvilinear fine vessels.

Entities:  

Mesh:

Year:  2012        PMID: 22552841     DOI: 10.1007/s00105-012-2383-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  12 in total

Review 1.  [Low malignancy myxofibrosarcoma versus low malignancy fibromyxoid sarcoma. Distinct entities with similar names but different clinical course].

Authors:  T Mentzel; D Katenkamp; C D Fletcher
Journal:  Pathologe       Date:  1996-03       Impact factor: 1.011

2.  Myxofibrosarcoma (myxoid malignant fibrous histiocytoma) showing cutaneous presentation: report of two cases.

Authors:  Taku Fujimura; Ryuhei Okuyama; Tadashi Terui; Kousei Okuno; Akiko Masu; Takashi Masu; Shuko Chiba; Takahide Kunii; Hachiro Tagami; Setsuya Aiba
Journal:  J Cutan Pathol       Date:  2005-08       Impact factor: 1.587

Review 3.  Surgical management of sarcomas.

Authors:  Edward Y Cheng
Journal:  Hematol Oncol Clin North Am       Date:  2005-06       Impact factor: 3.722

4.  Myxofibrosarcoma. A study of 30 cases.

Authors:  L Angervall; L G Kindblom; C Merck
Journal:  Acta Pathol Microbiol Scand A       Date:  1977-03

5.  Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.

Authors:  Hsuan-Ying Huang; Priti Lal; Jing Qin; Murray F Brennan; Cristina R Antonescu
Journal:  Hum Pathol       Date:  2004-05       Impact factor: 3.466

6.  Myxofibrosarcoma presenting in the skin: clinicopathological features and differential diagnosis with cutaneous myxoid neoplasms.

Authors:  Atiya Mansoor; Clifton R White
Journal:  Am J Dermatopathol       Date:  2003-08       Impact factor: 1.533

7.  Myxofibrosarcoma in the skin.

Authors:  Loren E Clarke; Paul J Zhang; Glen H Crawford; Rosalie Elenitsas
Journal:  J Cutan Pathol       Date:  2008-06-28       Impact factor: 1.587

Review 8.  The role of radiation therapy in the management of sarcomas.

Authors:  Aradhana Kaushal; Deborah Citrin
Journal:  Surg Clin North Am       Date:  2008-06       Impact factor: 2.741

9.  Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant.

Authors:  T Mentzel; E Calonje; C Wadden; R S Camplejohn; A Beham; M A Smith; C D Fletcher
Journal:  Am J Surg Pathol       Date:  1996-04       Impact factor: 6.394

10.  Reproducibility of a histopathologic grading system for adult soft tissue sarcoma.

Authors:  J M Coindre; M Trojani; G Contesso; M David; J Rouesse; N B Bui; A Bodaert; I De Mascarel; A De Mascarel; J F Goussot
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.